| Current Price | $9.46 | Mkt Cap | $371.2M |
|---|---|---|---|
| Open | $9.41 | P/E Ratio | -10.00 |
| Prev. Close | $9.46 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.28 - $9.54 | Volume | 379,638 |
| 52-Wk Range | $8.18 - $24.74 | Avg. Daily Vol. | 339,491 |
The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.
| Current Price | $9.46 | Mkt Cap | $371.2M |
|---|---|---|---|
| Open | $9.41 | P/E Ratio | -10.00 |
| Prev. Close | $9.46 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.28 - $9.54 | Volume | 379,638 |
| 52-Wk Range | $8.18 - $24.74 | Avg. Daily Vol. | 339,491 |
The best Bull and Bear pitches based on recency and number of recommendations.
AngioDynamics is forecasting that it will nearly triple its total addressable market from $3 billion last fiscal year to $8 billion by FY25. AngioDynamics also has a $10.5 million net cash position to support its growth ambitions. And the stock… More
I expect them to take a hit in litigation vs. Diomed.
Read the most recent pitches from players about ANGO.
Recs
TMFkodyk123
(36.89)
Submitted: 10/28/2021 4:41:40 PM :
Start Price:
$28.30
NASDAQ:ANGO Score:
-58.12
AngioDynamics is forecasting that it will nearly triple its total addressable market from $3 billion last fiscal year to $8 billion by FY25. AngioDynamics also has a $10.5 million net cash position to support its growth ambitions. And the stock trades at just 3.5 times this year's sales forecast, which is a good value considering its high-single-digit annual sales growth potential.
Recs
WilliamCrook2003
(71.52)
Submitted: 11/15/2013 3:43:56 AM :
Start Price:
$15.56
NASDAQ:ANGO Score:
-171.63
MF Stock of the day.
Recs
KatWoman50
(< 20)
Submitted: 3/7/2008 9:11:31 PM :
Start Price:
$10.05
NASDAQ:ANGO Score:
-240.93
Provider of medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease.
Acquired RITA in 2007 and now has a diverse product line that includes radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
Advance guidence on 3Q sales growth of 14% missed wallstreets expectations and sent the stock down 37% for the day. BUY BUY BUY
Find the members with the highest scoring picks in ANGO.
diefendb (< 20) Score: +275.94
The Score Leader is the player with the highest score across all their picks in ANGO.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| diefendb | < 20 | 3/7/2007 |
|
1Y | $22.86 | -58.62% | +217.32% | +275.94 | 1 Comment | |
| avatarslayer | < 20 | 3/28/2007 |
|
3W | $19.71 | -52.00% | +210.40% | +262.40 | 0 Comment | |
| kick6run2 | < 20 | 7/18/2011 |
|
1Y | $15.43 | -38.69% | +218.39% | +257.08 | 0 Comment | |
| devildoc8404 | 25.82 | 6/4/2008 |
|
1Y | $15.60 | -39.36% | +213.90% | +253.25 | 0 Comment | |
| megatraders | 91.92 | 3/10/2008 |
|
3W | $10.05 | -5.87% | +235.06% | +240.93 | 0 Comment | |
| MarketBottom | 27.50 | 4/4/2008 |
|
3M | $12.80 | -26.09% | +214.10% | +240.20 | 0 Comment | |
| e2nelson | < 20 |
|
|
1Y | $16.16 | -41.46% | +197.67% | +239.13 | 1 Comment | |
| anniejan | 41.42 | 10/1/2007 |
|
1Y | $19.68 | -51.93% | +186.52% | +238.45 | 0 Comment | |
| MRTShorts | 96.38 | 10/8/2007 |
|
NS | $20.57 | -54.01% | +181.39% | +235.40 | 0 Comment | |
| 3waystopsign | < 20 | 3/12/2008 |
|
3W | $10.20 | -7.25% | +227.23% | +234.48 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
